60 DEGREES PHARMACEUTICALS, INC.
SXTPWNasdaq
$0.03
↓ -2.7%Jul 17 close · end-of-day
Price
1Y↓ -47.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$50,046.98
Enterprise Value
-$3.1M
P/E
—
P/S
0.0
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
-16305.5%
Dividend Yield
—
Revenue (TTM)
$1.0M
Net Income (TTM)
-$7.6M
Free Cash Flow (TTM)
-$8.2M
Gross Margin
20.9%
Operating Margin
-791.1%
Net Margin
-754.8%
ROE
-156.9%
ROIC
-382.3%
Debt / Equity
0.0
Net Cash
$3.2M
Return 1Y
-51.7%
Earnings
SXTPW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$162,092.00↓ -0.9%
Diluted EPS-$1.28↓ -79.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $223,208.00 | $253,573.00 | $607,574.00 | $1.0M |
| Gross profit | -$209,162.00 | -$220,977.00 | $222,809.00 | $223,776.00 |
| Operating income | -$1.8M | -$5.2M | -$9.7M | -$7.8M |
| Net income | -$6.2M | -$3.8M | -$7.9M | -$7.4M |
| Diluted EPS | -$2.61 | -$59.18 | -$74.17 | -$11.73 |
| Operating cash flow | -$1.0M | -$4.5M | -$5.6M | -$6.8M |
| Free cash flow | — | -$4.6M | -$5.8M | -$7.0M |
| Gross margin | -93.7% | -87.1% | 36.7% | 22.3% |
| Operating margin | -784.2% | -2032.8% | -1599.0% | -771.6% |
| Net margin | -2769.5% | -1485.1% | -1308.0% | -732.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $124,972.00 | $135,293.00 | $241,635.00 | $163,552.00 | $100,932.00 | $437,602.00 | $303,385.00 | $162,092.00 |
| Gross profit | $35,408.00 | $23,606.00 | $123,558.00 | $90,280.00 | $50,881.00 | -$100,088.00 | $182,703.00 | $76,377.00 |
| Operating income | -$4.2M | -$2.1M | -$2.1M | -$1.9M | -$1.6M | -$2.3M | -$1.9M | -$2.1M |
| Net income | -$4.2M | -$2.2M | -$2.0M | -$1.9M | -$1.7M | -$2.3M | -$1.4M | -$2.1M |
| Diluted EPS | -$21.12 | -$2.92 | -$51.96 | -$6.25 | -$1.25 | -$0.66 | -$3.57 | -$1.28 |
| Operating cash flow | -$1.2M | -$1.7M | -$1.6M | -$1.6M | -$1.5M | -$2.1M | -$1.7M | -$2.7M |
| Free cash flow | — | -$1.7M | — | -$1.6M | -$1.5M | -$2.1M | -$1.8M | -$2.8M |
| Gross margin | 28.3% | 17.4% | 51.1% | 55.2% | 50.4% | -22.9% | 60.2% | 47.1% |
| Operating margin | -3351.8% | -1566.0% | -854.7% | -1168.4% | -1590.0% | -531.4% | -632.0% | -1292.5% |
| Net margin | -3339.0% | -1596.4% | -846.3% | -1147.4% | -1717.7% | -529.3% | -474.2% | -1288.9% |
Company news
Coming soonHeadlines for SXTPW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.